Stage III Ovarian Epithelial Cancer Completed Phase 2 Trials for Triapine (DB11940)

IndicationStatusPhase
DBCOND0028510 (Stage III Ovarian Epithelial Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT000812763-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal CancerTreatment